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Background: APRIL, originally known as a cytokine involved 
in B cell survival, is now known to regulate the inflammatory 
activation of macrophages. Although the signal initiated from 
APRIL has been demonstrated, its role in cellular activation is 
still not clear due to the presence of BAFF, a closely related 
member of TNF superfamily, which share same receptors 
(TACI and BCMA) with APRIL. Methods: Through trans-
fection of siRNA, BAFF-deficient THP-1 cells (human macro-
phage-like cells) were generated and APRIL-mediated in-
flammatory activities were tested. The expression patterns 
of APRIL were also tested in vivo. Results: BAFF-deficient 
THP-1 cells responded to APRIL-stimulating agents such as 
monoclonal antibody against APRIL and soluble form of TACI 
or BCMA. Furthermore, co-incubation of the siBAFF-defi-
cient THP-1 cells with a human B cell line (Ramos) resulted in 
an activation of THP-1 cells which was dependent on inter-
actions between APRIL and TACI/BCMA. Immunohisto-
chemical analysis of human pathologic samples detected the 
expression of both APRIL and TACI in macrophage-rich 
areas. Additionally, human macrophage primary culture ex-
pressed APRIL on the cell surface. Conclusion: These ob-
servations indicate that APRIL, which is expressed on macro-
phages in pathologic tissues with chronic inflammation, may 
mediate activation signals through its interaction with its 
counterparts via cell-to-cell interaction.
[Immune Network 2010;10(5):173-180]
INTRODUCTION
As members of the TNF superfamily (TNFSF), APRIL (TNFSF13) 
and its close relative BAFF (the B-cell activation factor of the 
TNF  family,  TALL-1,  THANK,  BlyS,  TNFSF13b,  zTNF-4)  are 
type II membrane proteins with a short cytoplasmic region, 
a transmembrane domain and an extracellular domain con-
sisting of a stalk and a TNF domain (1-4). Expression of both 
APRIL and BAFF were detected in various cell types including 
myeloid  cells  (monocytes,  macrophages,  neutrophils,  and 
dendritic cells), stromal cells within lymphoid organs, and os-
teoclasts  (5-8).  Mouse  models  either  transgenic  or  deficient 
in APRIL or BAFF revealed the essential role of these mole-
cules in B-cell survival, T cell co-stimulation, autoimmune dis-
eases  and  cancer  (4,6-8).  BAFF  and  APRIL  share  two  re-
ceptors,  TACI  (transmembrane  activator  and  CAML  [a  cal-
cium-modulating  cyclophilin  li g a n d ]  i n t e r a c t o r )  a n d  B C M A  
(B-cell  maturation  antigen),  while  BAFF-R  (BAFF  receptor, 
BR3) is recognized only by BAFF (6,8). Recently, both BAFF 
and  APRIL  has  been  demonstrated  to  induce  so-called 
‘reverse signaling’ when membrane-bound form of these mol-
ecules  were  stimulated  with  proper  agents  such  as  soluble 
form of their counterparts or agonistic monoclonal antibodies 
(mAbs)  against  them  (9,10). Upon  activation  through  BAFF 
or APRIL, macrophages undergo inflammatory changes which 
culminate at the induction of inflammatory mediators such as 
matrix  degrading  enzymes  and  pro-inflammatory  cytokines.
  Since APRIL and BAFF shares two of the three receptors, 
detailed analysis of the activity of APRIL is difficult to achieve. 
In an effort to study the role of APRIL in the inflammatory 
activation  of  macrophages  in  detail,  BAFF  expression  was 
suppressed  by  specific  siRNA.  The  resulting  BAFF-deficient Cellular Interaction Can Activate APRIL
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cells were stimulated with agents that can interact with APRIL 
or by direct incubation with cells that express  the counter-
parts  of  APRIL.  Additionally,  expression  patterns  of  APRIL 
were tested in pathologic samples obtained from patients and 
primary  macrophages  in  order  to  confirm  its  expression  in 
vivo.
MATERIALS AND METHODS
Monoclonal antibodies cells and reagents
The human monocytic leuk emia cell line, THP-1, were ob-
tained from the American Type Culture Collection (Rockville, 
MD, USA). Ramos cell line was a generously provided by Dr. 
Young-Hwa  Jung  (Busan  Univers i t y ) .  T h e  m A b s  f o r  A P R I L  
(clone  ab16088)  was  purchased  from  Abcam  (Cambridge, 
MA,  USA);  mAb  against  CD68  (clone  KP1)  was  purchased 
from  DAKO  Glostrup,  Denmark);  mAbs  for  BAFF  (clone 
121808) or TACI (clone 165609) and the fusion protein con-
taining an extracellular domain of hBCMA and the Fc portion 
of human IgG was obtained from R&D Systems (Minneapolis, 
MN, USA); mAb for BCMA (clone Vicky-1) and TACI:Fc came 
from Alexis (San Diego, CA, USA); PD08059 and U0126 origi-
nated from Cell Signaling (Danvers, MA, USA); human IgG, 
SB203580,  and  LY294002  were  obtained  from  Calbiochem 
International Inc. (La Jolla, CA, USA); and PMA, TPCK, ethyl 
pyruvate and sulfasalazine were  purchased  from Sigma (St. 
Luis,  MO,  USA).
Generation of BAFF-deficient cells by siRNA transfect-
ion
BAFF-specific siRNAs which contain a pool of 4 siRNAs for 
BAFF  and  control  siRNA  which  contains  random  base  se-
quence with no known specificity to human genes were pur-
c h a s e d  f r o m  D h a r m a c o n  I n c .  ( L a f a y e t t e ,  C o l o r a d o ,  U S A ) .  
Transfection  was  performed  as  described  previously  (10). 
Briefly, 5×10
3/well of THP-1 cells in 6 well plates were trans-
fected with 425μl  growth medium without  antibiotics  con-
taining 150× dilution of DharmaFECT (Dharmacon Inc.) and 
8 0  n M  o f  s i R N A .  S e v e n  t o  1 0  d a y s  a f t e r  t h e  t r a n s f e c t i o n ,  
down-regulation  of  cell  surface  BAFF  was  measured  using 
flow cytometry and the levels of mRNA was measured using 
RT-PCR.
RT-PCR
Five micrograms of total RNAs isolated from cells were treat-
ed with RNase free DNase (BD-Pharmingen), and then used 
to  generate  first-strand  cDNAs  using  the  RevertAid
TM f i r s t  
strand cDNA synthesis kit with 500 ng oligo (dT)12-18 primers. 
PCR primers were designed with ABI PRISM Primer Express 
2.0  (Applied  Biosystems)  and  made  by  Geno  Tech  Corp 
(Korea). Primer sequences are 5’ AGA AGA AGC AGC ACT 
CTG TC 3’  (forward) and 5’ CCA TGT GGA GAG AGG TTA 
AG 3’ (reverse) for APRIL, 5’ GGT CCA GAA GAA ACA GTC 
AC 3’ (forward) and 5’ GGA GTT CAT CTC CTT CTT CC 3’ 
(reverse)  for  BAFF,  and  5’ T G G  G C T  A C A  C T G  A G C  A C C 
AG 3’ (forward) and 5’ GGG TGT CGC TGT TGA AGT CA 
3 ’ ( r e v e r s e )  f o r  G A P D H .  A f t e r  t h e  P C R  r e a c t i o n ,  t h e  P C R  
products were run on 2% agarose gel to confirm the size and 
purity  of  the  PCR  products.
Gelatin zymogram and ELISA
The cells were activated by adding antibodies and fusion pro-
teins  to  the  medium  containing  1×10
6/ml  THP-1  cells  in 
RPMI1640 supplemented with 0.1% FBS. The culture super-
natants  were  collected  24  hours  after  activation  for  the  de-
tection of MMP-9 activity (gelatin zymogram) and the meas-
urement of cytokine concentrations (ELISA) as described pre-
viously  (11,12).
Primary culture of macrophages and histological 
analysis
Carotid endoarterectomy specimens, generously provided by 
Dr.  Jeong-Euy  Park,  Sungkyunkwan  University,  School  of 
Medicine, were obtained from patients, aged between 63 to 
81,  who  had  undergone  surgery  at  the  Samsung  Seoul 
Hospital. RA and osteoarthritis (OA) synovial samples, gen-
erously  provided  by  Dr.  Eun-Mi  Koh,  Sungkyunkwan 
University  School  of  Medicine,  were  obtained  from  RA  pa-
tients during joint replacement therapy. Cases of RA/OA were 
diagnosed according to the criteria of the American College 
of Rheumatology. Mononuclear cells were isolated from pe-
ripheral  blood  by  density  gradient  centrifugation  using  a 
Histopaque  (Sigma-Aldrich,  St.  Louis,  Missouri).  Adherent 
monocytes were isolated after 1 hr incubation and the cells 
were  incubated  for  1  week  to  induce  macrophage  differ-
entiation (13,14). The purity of the cells (＞95% CD14 pos-
itive cells) was then confirmed using flow cytometry. These 
studies were approved by an institutional review committee 
and the subjects provided informed consent. Specimens were 
washed with saline and embedded in an optimal cutting tem-
perature medium in order to make frozen sections. Standard 
5-μm  sections  were  stained  using  a  LSAB  Kit  (DAKO, Cellular Interaction Can Activate APRIL
Sang-Min Lee, et al.
175 IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 5 October 2010
Figure 1. Transfection of BAFF-specific siRNA resulted in a significant reduction of BAFF expression levels in THP-1 cells. (A) THP-1 cells transfected
with control siRNA (Control) or BAFF specific siRNA (siBAFF) were stained with anti-APRIL or anti-BAFF mAb. Histograms from specific staining
(open area) and background staining (filled area, stained with mouse IgG1) are compared. (B) RT-PCR analysis was performed in order to detect 
the presence of ARPIL, BAFF, or GAPDH mRNA in cells transfected with control siRNA (Control) or BAFF specific siRNA (siBAFF). PCR product
sizes for APRIL, BAFF, and GAPDH are 394, 370, and 391 bp, respectively. The results are representatives for three independent experiments.
Copenhagen,  Denmark),  according  to  instructions  provided 
b y  t h e  m a n u f a c t u r e r .
Statistical analysis
Statistical significance of differences was evaluated by means 
o f  a  t w o - s i d e d  S t u d e n t ’s  t t e s t ,  a s s u m i n g  e q u a l  v a r i a n c e s .  
Differences  were  considered  significant  when  p＜0.05.
RESULTS
BAFF-deficient cells responded to agents which can in-
teract with cell surface APRIL
THP-1 cells expressed high basal levels of both APRIL and 
BAFF on the cell membrane (9,10). In order to generate cells 
deficient in BAFF, THP-1 cells were transfected with BAFF- 
specific  siRNA  (siBAFF).  As  shown  in  Fig.  1A,  BAFF  ex-
pression levels were not detectable in cells transfected with 
s i B A F F  w h i l e  t h e  e x p r e s s i o n  l e v e l s  o f  A P R I L  w e r e  n o t  
affected. In contrast, cells transfected with control siRNA ex-
pressed  high  levels  of  both  APRIL  and  BAFF.  Accordingly, 
RT-PCR analysis of siBAFF-transfected cells detected the pres-
e nc e  o f A P RI L mR N A  w hi le  B A F F  mR N A  wa s n ot  de t ec t ed 
(Fig.  1B).
    Stimulation of either BAFF or APRIL can induce activation 
signal  in  THP-1  cells  which  respond  to  the  stimulation  via 
production of a cytokine, IL-8, or a matrix degrading enzyme, 
MMP-9 (9,10). The siBAFF-transfected cells were then tested 
for the responsiveness to BAFF or APRIL-mediated signaling. 
As shown in Fig. 2A, cells transfected with control siRNA re-
sponded  to  both  anti-BAFF  and  anti-APRIL  mAb  and  ex-
pressed  high  levels  of  IL-8.  Cells  transfected  with  siBAFF 
failed to respond to the treatment with anti-BAFF mAb but 
responded  to  anti-APRIL  mAb  at  a  level  similar  to  LPS 
response. The siBAFF-transfected cells were then treated with 
agents that mimic its counterparts such as fusion protein con-
taining extracellular domain of TACI (or BCMA) and Fc por-
tion of human immunoglobulin (TACI：Fc or BCMA：Fc). As 
shown in Fig. 2A, both TACI：Fc and BCMA：Fc stimulated 
the cells to express IL-8 at a level slightly less than that in-
duced by LPS treatment. Since stimulation of THP-1 cells with 
BCMA  ：Fc  had  not  been  reported  previously,  it  was  ana-
lyzed in detail. Treatment of THP-1 cells that are transfected 
with siBAFF resulted in a dose-dependent expression of both 
IL-8  and  MMP-9  (Fig.  2B).  These  results,  which  were  per-
formed in the absence of BAFF, clearly demonstrate that stim-
ulation  of  APRIL  with  either  its  counterparts  or  anti-APRIL 
m A b  l e a d s  t o  t h e  a c t i v a t i o n  o f  A P R I L .
Membrane-bound form of APRIL can be activated 
through interaction with cells expressing TACI or 
BCMA
Although APRIL-expressing cells responded to soluble agents 
such  as  anti-APRIL  mAb,  TACI：Fc,  or  BCMA：Fc,  these 
agents  are  not  generated  during  normal  immune  responses Cellular Interaction Can Activate APRIL
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Figure 2. THP-1 cells transfected with BAFF-specific siRNA were stimulated with agents that can interact with APRIL. (A) THP-1 cells transfected
with control siRNA (Control) or BAFF specific siRNA (siBAFF) were stimulated with 1μg/ml of LPS, TACI：Fc (TF), BCMA：Fc (BF), human
IgG (H), anti-APIRL mAb (A), anti-BAFF mAb (B), or mouse IgG. Culture supernatants were collected 24 hr after the activation and the concentration
of IL-8 was measured using double sandwich ELISA. IL-8 concentrations were compared with anti-APRIL stimulated samples which were set 
to 100%. (B) THP-1 cells transfected with siBAFF was stimulated with 1μg/ml LPS or 1, 3, 10μg/ml of BCMA：Fc for 24 hr. Culture supernatants
were then collected for the measurement of IL-8 concentration using ELISA and for the analysis of MMP-9 activity through gelatin zymogram.
Data points are represented as mean±SD of triplicate measurements. These experiments were repeated three times with essentially the same
results. *p＜0.001 when compared with negative control (the first lane). 
†p＜0.001 when compared with the value obtained without T/B 
pre-incubation.
o r  p a t h o l o g i c  c o n d i t i o n s .  I t  i s  m o r e  l i k e l y  t h a t  m e m -
brane-bound  form  of  APRIL  will  be  stimulated  through 
cell-to-cell interaction with cells expressing the counterparts 
of APRIL. In order to investigate the possibility, B cell lines 
were  used  for  co-incubation  experiment.  Both  BAFF  and 
APRIL  are  well  known  factors  required  for  B  cell  survival 
(6-8). Ramos cells, a human B cell line, expressed both TACI 
and  BCMA  on  the  cell  surface  at  high  levels  but  the  ex-
pression of APRIL was not detected (Fig. 3A). When Ramos 
cells were co-incubated with siBAFF-transfected THP-1 cells, 
the expression of both IL-8 and MMP-9 was induced. As ex-
pected, pre-incubation of Ramos cells with anti-TACI and an-
ti-BCMA mAb, but not isotype-matching mouse antibody, re-
sulted in a significant reduction of the stimulatory effects (Fig. 
3B). This indicates that THP-1 cells can be activated via spe-
cific  interaction  between  APRIL  and  its  counterparts  during 
c e l l - t o - c e l l  i n t e r a c t i o n .  T h e  r e s p o n s e  w a s  n o t  c o m p l e t e l y  
blocked by anti-TACI and anti-BCMA suggesting the involve-
ment of other cellular adhesion molecules for the activation 
of THP-1 cells during the cell-to-cell interaction with Ramos 
cells.
In vivo expression of APRIL and TACI can be detect-
ed in pathologic samples with inflammatory condit-
ions
Detection  of  APRIL  expression  in  monocytic  cell  lines  and 
m o d u l a t i o n  o f  i n f l a m m a t o r y  a c t i v i t y  t h r o u g h  A P R I L  i n d i c a t e  
that  APRIL  may  play  an  immunoregulatory  function  during 
acute and chronic inflammation where macrophages play a 
major  role  (15-17).  In  order  to  determine  whether  macro-
phages  express  APRIL  in  vivo,  t is su e s am ple s fr om  c hr on ic 
inflammatory diseases were analyzed. CD68 was detected as 
a  specific  marker  for  human  macrophages  (18).  In  human 
a t h e r o s c l e r o t i c  p l a q u e s ,  w h e r e  m a c r o p h a g e s  a r e  p r e s e n t  i n  
the form of foam cells, a CD68 positive macrophage rich-area 
was also stained with anti-APRIL mAb (Fig. 4). It is of interest 
that TACI, which is one of the natural counterparts of APRIL, 
w a s  a l s o  e x p r e s s e d  i n  t h e  s a m e  a r e a .
  The expression of APRIL and TACI was also tested in syno-
vial tissues from rheumatoid arthritis (RA) and osteroarthritis 
(OA) patients (Fig. 5A and B). RA tissue samples tended to 
have more inflammatory cells than OA tissue samples since 
RA  is  an  autoimmune  disease  where  chronic  synovial  in-
flammation destroys the normal architecture of cartilage and 
bone.  Macrophages  also  play  important  roles  in  RA 
development. The destruction of joint tissue has close correla-Cellular Interaction Can Activate APRIL
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Figure 3. Ramos cells stimulated THP-1 cells through interaction 
between APRIL and its counterparts. (A) Ramos cells were stained with
mAb against TACI, BCMA, or APRIL. Histograms from specific staining
(open area) and background staining (filled area, stained with mouse
IgG1) are compared. (B) SiBAFF-transfected THP-1 cells were 
stimulated with either 1μg/ml of anti-APRIL mAb (A) or co-incubation
with Ramos cells. For the blocking, Ramos cells were pre-incubated
with 1μg/ml of anti-TACI/anti-BCMA (T/B) mixture or mouse IgG (M)
for 20 min. After washing out the antibodies, cells were then 
incubated with siBAFF-transfected THP-1 cells. Data points are 
represented as mean±SD of triplicate measurements. These 
experiments were repeated twice with essentially the same results. *p
＜0.001 when compared with negative control (the first lane). 
†p
＜0.001 when compared with the value obtained without T/B 
pre-incubation.
Figure 4. Macrophages in human atherosclerotic plaques express both APRIL and TACI. Consecutive sections of an atherosclerotic plaque were 
stained with mAbs against CD68 (a marker for macrophages), APRIL, or TACI. Isotype-matching mouse immunoglobulins (mIgG) were used for
staining as a negative control. Magnification: ×100. The results are representative for three independent analyses.
tion with the number of macrophages (19-21) that infiltrate 
the  synovium  and  the  selective  depletion  of  macrophages 
from  the  synovial  lining  prevented  both  joint  inflammation 
and  cartilage  destruction  (22-24).  Macrophage-rich  areas  in 
these tissues expressed both APRIL and TACI, albeit the levels 
were  much  higher  in  RA  tissues.  Interestingly,  APRIL  and 
TACI were detected in areas that were not stained for CD68 
in RA tissues. This may be due to the expression of APRIL 
and TACI in cell types other than macrophage or the shed-
ding and subsequent secretion of these cell surface molecules 
by macrophages to the surroundings. Alternatively, it is also 
possible  that  other  cell  types,  such  as  smooth  muscle  cells 
or synovial fibroblasts, may express these molecules. The ex-
pression of BCMA was not detected in either RA or OA tissue 
samples  (data  not  shown).
  Expression of APRIL and TACI by macrophage was further 
confirmed in primary macrophages which are derived from 
peripheral blood monocytes of RA patients. It is well known 
that incubation of peripheral blood monocytes for a week in-
duce  macrophage  differentiation  (13,14).  In  order  to  detect 
the  expression  of  APRIL  and  TACI  on  the  surface  of  these 
cells, mAbs and secondary antibodies were added to live pri-
mary macrophages before the fixation of the cells. Staining 
results confirmed that CD68-expressing macrophages express 
high levels of both APRIL and TACI on the cell surface (Fig. 6).
DISCUSSION
APRIL and BAFF are members of TNFSF and closely related 
with each other in their molecular structure and, as a result, 
s h a r e  s a m e  r e c e p t o r s ,  T A C I  a n d  B C M A .  S i n c e  A P R I L  a n d  Cellular Interaction Can Activate APRIL
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Figure 5. Expression of both APRIL and TACI was in macrophages from human arthritic synovial tissues. Consecutive sections of an atherosclerotic
plaque RA-synovial tissue (A) or osteoarthritis tissues (B) were stained with mAbs against CD68, APRIL, or TACI. Isotype-matching mouse 
immunoglobulins (mIgG) were used for staining as a negative control. Magnification: ×100. The results are representative for three independent
analyses.
Figure 6. Primary macrophage culture expresses APRIL and TACI on the cell surface. Primary macrophages derived from RA patient peripheral
blood monocytes were stained with mAbs against CD68, APRIL, or TACI. In case APPRIL and TACI, specific mAbs were added before fixation 
and mounting in order to detect the expression of these molecules on the cell surface. Isotype-matching mouse immunoglobulins (mIgG) were
used for staining as a negative control. Magnification: ×400. The experiment was repeated twice with essentially the same results.
BAFF  share  the  receptors,  distinction  between  APRIL-medi-
ated  signaling  and  BAFF-mediated  signaling  was  difficult. 
Suppression of BAFF expression by siRNA technique allowed 
expression of only APRIL. The resulting APRIL positive and 
BAFF negative cells were then used for so-culture experiment 
with human B cell line, Ramos that expresses both TACI and 
BCMA. Current data demonstrate that membrane-bound form 
of  APRIL  responds  to  its  counterparts  through  cell-to-cell 
interaction.
    Previously,  the  extracellular  domain  of  APRIL  has  been Cellular Interaction Can Activate APRIL
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shown to be expressed on the surface of U937 cells as fusion 
protein called TWE-PRIL which contains intracellular domain 
of TWEAK and extracellular domain of ARIIL (25,26). Since 
the primer used in the experiment cannot distinguish ARPIL 
and TWE-PRIL, new primer sets that can specifically amplify 
APRIL, TWEAK, and TWE-PRIL were used to compare normal 
and siAPRIL transfected THP-1 cells. Results indicated that on-
ly APRIL is expressed in THP-1 cells and the expression of 
TWEAK and TWE-PRIL was not detected. The siAPRIL trans-
fected cells expressed none of them (data not shown). These 
results indicate that APRIL, not TWE-PRIL, is responsible for 
the interaction with its counterparts in THP-1 cells and APRIL 
can  generate  activation  signals.
    The expression of both APRIL and its natural counterpart 
in tissue macrophages raises the possibility that APRIL-medi-
ated regulation of macrophage activity does play a role dur-
ing  immune  responses  such  as  inflammation  and  in  patho-
genic processes associated with atherosclerosis and/or arthri-
tis.  Stimulation  of  APRIL-expressing  macrophages  though 
cell-to-cell  interaction  with  the  counterpart-expressing  cells 
may induce inflammatory activation of these cells. In chroni-
cally-inflamed, diseased tissue samples, macrophages appear 
to be the major cell type that express APRIL and its receptor. 
These  molecules,  in  addition t o  p r o - i n f l a m m a t o r y  a g e n t s  
which are already known to be expressed by macrophages, 
will  enhance  the  inflammatory  responses  and  contribute  to 
the  pathogenesis  of  these  diseases.  Further  research  is  re-
quired in animal models and clinical settings in order to iden-
tify the importance of APRIL-mediated signaling in the modu-
l a t i o n  o f  i m m u n e  r e s p o n s e s  a n d  p a t h o g e n e s i s .
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